Cargando…
Conditional relative survival in primary central nervous system lymphoma: a population-based study in the Netherlands
Autores principales: | Dinmohamed, Avinash G, van der Meulen, Matthijs, Visser, Otto, Doorduijn, Jeanette K, Bromberg, Jacoline E C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668442/ https://www.ncbi.nlm.nih.gov/pubmed/33235997 http://dx.doi.org/10.1093/noajnl/vdaa133 |
Ejemplares similares
-
Primary therapy and survival in patients over 70 years old with primary central nervous system lymphoma: a contemporary, nationwide, population-based study in the Netherlands
por: van der Meulen, Matthijs, et al.
Publicado: (2020) -
The Role of Rituximab in Primary Central Nervous System Lymphoma
por: Bromberg, Jacoline E. C., et al.
Publicado: (2020) -
MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma
por: van der Meulen, Matthijs, et al.
Publicado: (2021) -
Treatment and Survival of Patients With Primary Effusion Lymphoma in the Netherlands: A Population-based Analysis, 2002–2015
por: Dinmohamed, Avinash G., et al.
Publicado: (2018) -
The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
por: Van Dijck, Ruben, et al.
Publicado: (2021)